The latest news updates from the 2024 Symposium
Joshua Z. Drago, MD, MS, discusses a Tuesday afternoon presentation on antibody-drug conjugate development across tumor types.
Ashley M. Laughney, PhD, discusses a Tuesday afternoon presentation on the effect of cellular interactions with the tumor microenvironment based on intrinsic single cell variability.
Melinda L. Telli, MD, will deliver the second plenary lecture at the 2023 SABCS® on how the emergence of immunotherapy and antibody drug conjugation has changed the field of triple-negative breast cancer and increased options for patients.
The 2023 SABCS® will feature multiple presentations on breast cancer risk reduction and prevention, including a discussion of obesity-associated breast cancer risk moderated by Abenaa M. Brewster, MD, MHS.
Komal Jhaveri, MD, FACP, will moderate a lightning-quick discussion of challenging or controversial topics, including low-dose tamoxifen, window-of-opportunity trials, and tumor sequencing timing.
Joanne Kotsopoulos, MSc, PhD, discusses her Tuesday, December 5, presentation on cancer risk associated with exogenous hormone use in BRCA mutation carriers.
Barbara Segarra-Vazquez, DHSc, discusses her Tuesday, December 5, presentation on screening for health-related social needs.
Jack Cuzick, PhD, has been chosen as the 2023 recipient of the William L. McGuire Memorial Lecture Award and will share insights on progress in the prevention of breast cancer.
Charles Swanton, MB, PhD, FRS, FAACR, FRCP, will give the first plenary lecture at the 2023 SABCS® on breast cancer evolution, immune evasion, and metastasis.
Mia Levy, MD, PhD, will discuss real-world data as it relates to tumor agnostic approaches to care during a clinical workshop at SABCS®.